A therapeutic antibody is the first success in a wave of experimental therapies aimed at tackling the autoimmune disease.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Related links
Related links
Related links in Nature Research
Nature Reviews Drug Discovery correspondence: Genomics drugs in clinical trials
Related external links
Rights and permissions
About this article
Cite this article
Ledford, H. First lupus drug in half a century approved. Nature (2011). https://doi.org/10.1038/news.2011.150
Published:
DOI: https://doi.org/10.1038/news.2011.150